Results of one-way sensitivity analyses comparing apixaban to adjusted-dose warfarin: parameters for which variations result in positive incremental cost-effectiveness ratios.

ICH = intracranial hemorrhage; INR = international normalized ratio.*Value of variable at which apixaban was no longer found to be a dominant economic strategy.